Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06885060Active Not Recruiting

Exploring Eye Vergence Markers ADHD) and ASD

Role: collaborator

NCT06963879Not ApplicableEnrolling By Invitation

Validation Study of a New Digital Diagnostic and Treatment Test Based on Interactive Video Games for Alzheimer's Disease

Role: lead

NCT04897464Not ApplicableUnknown

Validation Study of a New Digital Treatment Test

Role: lead

All 3 trials loaded